Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Pozen and Tribute combine to form Aralez Pharmaceuticals

Executive Summary

US biotech Pozen Inc. paid $146mm to acquire public Canadian company Tribute Pharmaceuticals Canada Inc., forming Aralez Pharmaceuticals PLC, which will trade on Nasdaq and TSX and be domiciled in Ireland.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Medical Devices
    • Biomaterials
    • Implantable Devices
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Payment Includes Cash
    • Full Acquisition

Related Companies

UsernamePublicRestriction

Register